ABSENCE OF AN ANXIOLYTIC EFFECT OF THE 5-HT2C/2B ANTAGONIST SB200646A IN THE CONDITIONED EMOTIONAL RESPONSE MODEL OF ANXIETY IN THE RAT

被引：0
|
作者：
OXLEY, K [1 ]
STANHOPE, KJ [1 ]
SHEPHERD, JK [1 ]
CRONIN, S [1 ]
DOURISH, CT [1 ]
机构：
[1] WYETH RES UK LTD,DEPT NEUROPHARMACOL,TAPLOW SL6 0PH,BERKS,ENGLAND
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1995年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P215 / P215
页数：1
相关论文
共 50 条
  • [31] THE PHARMACOLOGY AND DISTRIBUTION OF HUMAN 5-HYDROXYTRYPTAMINE(2B) (5-HT2B) RECEPTOR GENE-PRODUCTS - COMPARISON WITH 5-HT2A AND 5-HT2C RECEPTORS
    BONHAUS, DW
    BACH, C
    DESOUZA, A
    SALAZAR, FHR
    MATSUOKA, BD
    ZUPPAN, P
    CHAN, HW
    EGLEN, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (04) : 622 - 628
  • [32] Role of 5-HT2A and 5-HT2C/2B receptor subtypes in the control of in vivo dopamine release induced by amphetamine and morphine in the rat nucleus accumbens and striatum
    Porras, G
    De Deurwaedère, P
    Caccia, S
    Spampinato, U
    MONITORING MOLECULES IN NEUROSCIENCE, 2001, : 280 - 281
  • [33] A 5-HT2C receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference
    McCorvy, John D.
    Harland, Aubrie A.
    Maglathlin, Rebecca
    Nichols, David E.
    NEUROSCIENCE LETTERS, 2011, 505 (01) : 10 - 13
  • [34] 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum
    Porras, G
    Di Matteo, V
    Fracasso, C
    Lucas, G
    De Deurwaerdère, P
    Caccia, S
    Esposito, E
    Spampinato, U
    NEUROPSYCHOPHARMACOLOGY, 2002, 26 (03) : 311 - 324
  • [35] 5-HT2A and 5-HT2C/2B Receptor Subtypes Modulate Dopamine Release Induced in Vivo by Amphetamine and Morphine in Both the Rat Nucleus Accumbens and Striatum
    Grégory Porras
    Vincenzo Di Matteo
    Claudia Fracasso
    Guillaume Lucas
    Philippe De Deurwaerdère
    Silvio Caccia
    Ennio Esposito
    Umberto Spampinato
    Neuropsychopharmacology, 2002, 26 : 311 - 324
  • [36] Effect of Combined Administration of Afobazole and 5-HT2b/2c Receptor Antagonist SB-200646A on Neurochemical Profile of Brain Structures in C57Bl/6 and BALB/c Mice
    K. S. Rayevsky
    V. B. Narkevich
    P. M. Klodt
    V. S. Kudrin
    Bulletin of Experimental Biology and Medicine, 2012, 153 : 689 - 693
  • [37] 5-HT depletion, but not 5-HT1A antagonist, prevents the anxiolytic-like effect of citalopram in rat contextual conditioned fear stress model
    Masuda, Takahiro
    Nishikawa, Hiroyuki
    Inoue, Takeshi
    Toda, Hiroyuki
    Nakagawa, Shin
    Boku, Shuken
    Koyama, Tsukasa
    ACTA NEUROPSYCHIATRICA, 2013, 25 (02): : 77 - 84
  • [38] Functional potencies of novel human 5-HT2C/2B receptor antagonists determined in the cytosensor microphysiometer
    Boyfield, I
    Gager, TL
    Coldwell, MC
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P139 - P139
  • [39] Synthesis, biological activity, and molecular modeling studies of selective 5-HT2C/2B receptor antagonists
    Forbes, IT
    Dabbs, S
    Duckworth, DM
    Ham, P
    Jones, GE
    King, FD
    Saunders, DV
    Blaney, FE
    Naylor, CB
    Baxter, GS
    Blackburn, TP
    Kennett, GA
    Wood, MD
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) : 4966 - 4977
  • [40] Effect of Combined Administration of Afobazole and 5-HT2b/2c Receptor Antagonist SB-200646A on Neurochemical Profile of Brain Structures in C57Bl/6 and BALB/c Mice
    Rayevsky, K. S.
    Narkevich, V. B.
    Klodt, P. M.
    Kudrin, V. S.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 153 (05) : 689 - 693
12345